Successful treatment of eosinophilic gastroenteritis with suplatast tosilate.
Shirai
T
T
Hashimoto
D
D
Suzuki
K
K
Osawa
S
S
Aonahata
M
M
Chida
K
K
Nakamura
H
H
D018926:Anti-Allergic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001190:Arylsulfonates / Q000494:pharmacology / Q000627:therapeutic use*; D001249:Asthma / Q000150:complications / Q000188:drug therapy; D003864:Depression, Chemical; D004802:Eosinophilia / Q000150:complications / Q000188:drug therapy*; D005759:Gastroenteritis / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D015847:Interleukin-4 / Q000378:metabolism; D015848:Interleukin-5 / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D012636:Secretory Rate / Q000187:drug effects; D013452:Sulfonium Compounds / Q000494:pharmacology / Q000627:therapeutic use*; D018418:Th2 Cells / Q000187:drug effects / Q000378:metabolism
D018926:Anti-Allergic Agents; D018927:Anti-Asthmatic Agents; D001190:Arylsulfonates; D015848:Interleukin-5; D013452:Sulfonium Compounds; D015847:Interleukin-4; C073028:suplatast tosilate